JPWO2021236548A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021236548A5 JPWO2021236548A5 JP2022570271A JP2022570271A JPWO2021236548A5 JP WO2021236548 A5 JPWO2021236548 A5 JP WO2021236548A5 JP 2022570271 A JP2022570271 A JP 2022570271A JP 2022570271 A JP2022570271 A JP 2022570271A JP WO2021236548 A5 JPWO2021236548 A5 JP WO2021236548A5
- Authority
- JP
- Japan
- Prior art keywords
- tcr
- seq
- polypeptide
- amino acid
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063026445P | 2020-05-18 | 2020-05-18 | |
| US63/026,445 | 2020-05-18 | ||
| PCT/US2021/032818 WO2021236548A1 (en) | 2020-05-18 | 2021-05-17 | Engineered t cell receptors and methods of use |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2023528255A JP2023528255A (ja) | 2023-07-04 |
| JP2023528255A5 JP2023528255A5 (https=) | 2024-05-28 |
| JPWO2021236548A5 true JPWO2021236548A5 (https=) | 2024-05-28 |
| JP7785696B2 JP7785696B2 (ja) | 2025-12-15 |
Family
ID=78708026
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022570271A Active JP7785696B2 (ja) | 2020-05-18 | 2021-05-17 | 操作されたｔ細胞受容体および使用の方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230190812A1 (https=) |
| EP (1) | EP4153618A4 (https=) |
| JP (1) | JP7785696B2 (https=) |
| CN (1) | CN116322715A (https=) |
| AU (1) | AU2021276264A1 (https=) |
| CA (1) | CA3183663A1 (https=) |
| TW (1) | TWI907427B (https=) |
| WO (1) | WO2021236548A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3236237A1 (en) * | 2021-10-25 | 2023-05-04 | Board Of Regents, The University Of Texas System | Peptides and engineered t cell receptors targeting mage-a4 antigen and methods of use |
| CN114149978B (zh) * | 2022-02-09 | 2022-04-26 | 深圳博雅感知药业有限公司 | 制备car-t细胞的方法 |
| CN116836261A (zh) * | 2022-03-24 | 2023-10-03 | 香雪生命科学技术（广东）有限公司 | 一种识别mage-a4抗原的高亲和力tcr及其序列和应用 |
| JP2026505826A (ja) | 2023-02-03 | 2026-02-18 | ゼルナ・イミュノセラピー・アーエス | 抗ｍａｇｅ－ａ４ ｔ細胞受容体 |
| CN120924527B (zh) * | 2025-10-16 | 2026-02-06 | 内蒙古科为博生物科技有限公司 | 一种内切葡聚糖酶突变体eg06、其编码基因及其产品与应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3173480A3 (en) * | 2007-03-05 | 2017-08-16 | International Institute of Cancer Immunology, Inc. | Cancer antigen-specific t-cell receptor gene, peptide encoded by the gene, and use of them |
| CN102272153B (zh) * | 2008-11-24 | 2015-04-15 | 德国慕尼黑亥姆霍兹研究中心健康和环境有限公司 | 高亲和力t细胞受体及其应用 |
| GB0911566D0 (en) * | 2009-07-03 | 2009-08-12 | Immunocore Ltd | T cell receptors |
| KR20140039318A (ko) * | 2011-06-28 | 2014-04-01 | 인터내셔널 인스티튜트 오브 캔서 이무놀로지 인코퍼레이티드 | 펩티드 암 항원 특이적 ｔ 세포의 리셉터 유전자 |
| CN106103711A (zh) * | 2013-11-21 | 2016-11-09 | 组库创世纪株式会社 | T细胞受体和b细胞受体库分析系统及其在治疗和诊断中的应用 |
| US11047011B2 (en) * | 2015-09-29 | 2021-06-29 | iRepertoire, Inc. | Immunorepertoire normality assessment method and its use |
| PL3440105T3 (pl) * | 2016-04-08 | 2022-08-29 | Immunocore Limited | Receptory komórek t |
| AU2018318303A1 (en) * | 2017-08-18 | 2020-04-09 | Gritstone Bio, Inc. | Antigen-binding proteins targeting shared antigens |
| US20210061914A1 (en) * | 2017-12-28 | 2021-03-04 | Gritstone Oncology, Inc. | Antigen-Binding Proteins Targeting Shared Antigens |
| EP3731861A1 (en) * | 2017-12-29 | 2020-11-04 | Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft | T cell receptors for tumor specific proteasome splice variants and uses thereof |
| EP3749753B1 (en) * | 2018-02-09 | 2025-04-02 | Immatics US, Inc. | Methods for manufacturing t cells |
| DE102018108612A1 (de) * | 2018-03-21 | 2019-09-26 | Immatics US, Inc. | Verfahren zur erhöhung der persistenz von adoptiv infundierten t-zellen |
| EP3962939A4 (en) * | 2019-05-03 | 2023-05-17 | Gigamune, Inc. | MODIFIED CELLS EXPRESSING ANTITUMOR T-LYMPHOCYTE RECEPTORS AND METHODS OF USING THEM |
-
2021
- 2021-05-17 WO PCT/US2021/032818 patent/WO2021236548A1/en not_active Ceased
- 2021-05-17 AU AU2021276264A patent/AU2021276264A1/en active Pending
- 2021-05-17 JP JP2022570271A patent/JP7785696B2/ja active Active
- 2021-05-17 US US17/998,914 patent/US20230190812A1/en active Pending
- 2021-05-17 EP EP21807947.3A patent/EP4153618A4/en active Pending
- 2021-05-17 CA CA3183663A patent/CA3183663A1/en active Pending
- 2021-05-17 CN CN202180049915.XA patent/CN116322715A/zh active Pending
- 2021-05-18 TW TW110117938A patent/TWI907427B/zh active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN109734813B (zh) | 一种嵌合抗原受体及其应用 | |
| AU2014225788B2 (en) | Engager cells for immunotherapy | |
| CN113286879A (zh) | 用于细胞疗法之多样化抗原结合域、新颖平台及其他增强子 | |
| CN118580363A (zh) | 制导和导航控制蛋白及其制备和使用方法 | |
| CN110818802A (zh) | 一种嵌合t细胞受体star及其应用 | |
| CN106397593A (zh) | 抗磷脂酰肌醇蛋白多糖‑3的抗体及其应用 | |
| CN111826353A (zh) | 调节t细胞功能和反应的方法 | |
| CN111040036A (zh) | 抗gpc3单克隆抗体、由其修饰的免疫效应细胞及其应用 | |
| CN112048018A (zh) | 一种嵌合t细胞生长因子及其应用 | |
| CN116284419B (zh) | 靶向人gucy2c蛋白的单克隆抗体及其应用 | |
| JPWO2021236548A5 (https=) | ||
| CN114286863A (zh) | 一种双特异性嵌合抗原受体 | |
| CN113321727A (zh) | 一种识别afp抗原短肽的t细胞受体及其编码序列 | |
| Haas et al. | Bispecific antibodies increase T-cell stimulatory capacity in vitro of human autologous virus-modified tumor vaccine. | |
| JPWO2022098845A5 (https=) | ||
| CN109641032A (zh) | 用于治疗黑素瘤的方法和组合物 | |
| CN117924519A (zh) | 靶向cd138的嵌合抗原受体 | |
| CN111434691A (zh) | Pd-l2单克隆抗体及其应用 | |
| CN117304320A (zh) | 靶向小鼠clec12b蛋白的纳米抗体及其应用 | |
| JPWO2021252517A5 (https=) | ||
| CN117659162A (zh) | 一种识别apf的t细胞受体及其编码序列和应用 | |
| WO2024007358A1 (zh) | 一种结合人cd207的抗体、抗人cd207的嵌合抗原受体及其应用 | |
| CN117106059A (zh) | 一种识别mage的t细胞受体及其应用 | |
| CN110016074A (zh) | Mage-a3人源化t细胞受体 | |
| Lucansky et al. | DNA vaccination against bcr-abl-positive cells in mice |